decoration

Poids de l’Open access dans la production CNRS

Titre
Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR)
BSO - Titre
Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR)
DOI
DOAI
Identifiant WoS
WOS:000415777200002
Accès ouvert
OA - Non
Source - Accès ouvert
OA - Non
Type d'accès
Non OA
Editeur

Elsevier

Source

GROWTH HORMONE & IGF RESEARCH

ISSN
1096-6374
Type de document
  • Article
Notoriété
2 - Acceptable
CNRS
Oui
CNRS - Institut
  • INSB - Institut des sciences biologiques
uid:/8045V6FR
Powered by Lodex 9.6.0
decoration